The largest database of trusted experimental protocols

4 protocols using anti human cd3 mab okt3

1

CXCR3 Expression in Activated Naive CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4+ T cells were isolated from 30 mL fresh peripheral blood obtained from healthy volunteers by magnetic cell sorting using a human naïve CD4+ T cell isolation kit II (Miltenyi Biotec, USA). The purity of naïve CD4+ T cells was greater than 95%, as determined by flow cytometry. Then, the isolated naïve CD4+ T cells were resuspended in RPMI 1640 medium containing 10% fetal bovine serum (Gibco, USA) and diluted to 5×105 cells/mL. The cells were cultured at 37°C in 48-well plates and stimulated with plate-bound anti-human CD3 mAb (OKT3; 5 µg/mL; eBioscience, USA) and anti-human CD28 mAb (5 µg/mL; eBioscience, USA) in the presence of IL-2 (5 ng/mL; PeproTech, USA) for four days. To assess the influence of ICOS signaling on CXCR3 expression, anti-ICOS mAb (ISA-3; 5 µg/mL; eBioscience, 16–9948-82, USA) was added to the culture medium.
+ Open protocol
+ Expand
2

Generation and Infusion of iCART Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs used to prepare primary CART cells were purchased from Precision for Medicine and the use of human samples was approved by ethical committee at Takeda Pharmaceutical Company Ltd. To transduce CAR, T cells were cultured on wells precoated with CD3/retronectin solution composed of 3.0 μg/ml anti-human CD3 MAb (OKT3; eBioscience) and 150 μg/ml retronectin (TAKARA), having T-cell activation medium composed of CTS OpTmizer T Cell Expansion SFM supplemented with CTS Immune Cell Serum Replacement (Thermo Fisher Scientific), supplemented with 400 IU/ml recombinant human IL-2 (PeproTech) for 3 days for activation. The activated T cells were transduced with retroviral vector harboring 19BBz, as described in the above section (Generation of iCART cells). The resulting cells were infused into NALM-6-bearing mice 4 days after transduction.
+ Open protocol
+ Expand
3

Isolation and Stimulation of CD4+ T-cells and NK-cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+T-cells were isolated from frozen PBMCs. All CD4+T-cells were positively selected with a CD4+T-cell isolation kit (Miltenyi Biotec, Germany), yielding CD4+T-cell populations at a purity of 96–99%. Purified CD4+T-cells were stimulated as described previously (28 (link)) with 4 μg/mL plate-bound anti-human CD3 (OKT3) mAb (eBioscience, San Diego, CA) and 4 μg/mL soluble anti-human CD28 (CD28.2) mAb (Becton Dickinson) in presence of Recombinant human IL-2 (Proleukine, Chiron, Amsterdam, 100 U/mL) and recombinant human interferon alpha-2a (Roferon-A) and IFNλ2 (Biotechne, UK) at the indicated dose. After five days culture, CD38 and CD25 expression as well as the frequency of 7AAD+ cells were measured by flow cytometry on stimulated CD4+T-cells (Table S4). NK-cells were isolated from PBMCs. NK-cells were negatively selected with the NK-cell isolation kit (Miltenyi Biotec, Germany), yielding NK-cell populations at a purity of 96–99%. NK-cells were stimulated with IL-15 (Miltenyi Biotec, 10 ng/mL), IL-2 (Proleukine, Chiron, Amsterdam 100 U/mL) and recombinant human interferon alpha-2a (Roferon-A) at the indicated dose. After 3 days of culture, expression of CD56, CD95 and NKG2D was measured by flow cytometry (extended data Table 3a).
+ Open protocol
+ Expand
4

CD4+ T Cell Activation and CCR5 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were isolated from frozen PBMCs. All CD4+ T cells were positively selected with a CD4+ T cell isolation kit (Miltenyi Biotec, Bergisch-Gladbach, Germany), yielding CD4+ T cell populations at a purity of 96–99%. Purified CD4+ T-cells were stimulated as described previously (20 (link)) with 4 μg/mL plate-bound anti-human CD3 (OKT3) mAb (eBioscience, San Diego, CA) and 4 μg/mL soluble anti-human CD28 (CD28.2) mAb (Becton Dickinson) in presence of Recombinant human IL-2 (Proleukine, Chiron, Amsterdam, 100 U/mL) and recombinant human interferon alpha-2a (Roferon-A 0.01–100 ng/mL). After four days culture, membrane CCR5 expression was measured by flow cytometry on CD4+ T cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!